Abstract: The present invention provides methods of treating arthritis. A sustained release composition comprising liposomes and one or more therapeutic agent or a pharmaceutically acceptable salt thereof is administered to a subject in need thereof. The liposomes may be in an aqueous suspension. The sustained release composition can be administered intraarticularly.
Type:
Grant
Filed:
June 12, 2019
Date of Patent:
August 11, 2020
Assignees:
TAIWAN LIPOSOME CO., LTD., TCL BIOPHARMACEUTICALS, INC.
Inventors:
Keelung Hong, Luke S. S. Guo, Yun-Long Tseng, Sheue-Fang Shih, Po-Chun Chang, Chih-Chiang Tsai, Hong-Hui Lin